Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, March 08, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on March 6, 2024, the Compensation Committee of Cardlytics’s Board of Directors granted an aggregate of 198,183 restricted stock units of Cardlytics to 8 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

The 8 newly hired employees were granted restricted stock units on one of two different vesting schedules. For some of the grant recipients, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to the employees’ continuous service with Cardlytics through the vesting date. For the other grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees’ continuous service with Cardlytics through the vesting date. The restricted stock units are subject to the terms and conditions of the 2022 Inducement Plan.

About Cardlytics

Cardlytics (NASDAQ: CDLX) is a digital advertising platform. We partner with financial institutions to run their rewards programs that promote customer loyalty and deepen relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in New York, NY; Menlo Park, CA; Los Angeles, CA; Champaign, IL; and London, U.K. Learn more at www.cardlytics.com.

Contacts:

Public Relations:
[email protected]

Investor Relations:
[email protected]